98%
921
2 minutes
20
Background: Salmonella, is among the leading cause of foodborne illnesses in humans, is primarily sourced from food-producing animals. The prevalence of multidrug-resistant Salmonella species has significantly increased in recent years.
Methods: A cross-sectional study was conducted from November 2022 to May 2023 to determine the prevalence and antimicrobial susceptibility pattern of Salmonella in apparently healthy slaughtered cattle and abattoir personnel at Gondar Elfora abattoir. The study was conducted 253 samples in total, including 75 carcass swabs, 75 liver tissue samples, 75 intestinal contents samples, and 14 stool and 14 water samples from the slaughterhouse. Salmonella isolates were identified using standard isolation and identification techniques. Each isolate was also subjected to Kirby-Bauer disc diffusion tests for antimicrobial susceptibility. STATA version 14 was used to compute and analyses various data from slaughterhouses, antimicrobial susceptibility test results, and animal samples using descriptive statistics.
Results: The overall proportion of Salmonella positive isolates was 13.4%( 253/34) in difference sample sources. The prevalence of Salmonella in cattle was 12% (27/225), of which 17.3% were from carcass swabs, 10.7% were from liver tissue, 8% were from intestinal contents, 14.3% were from human stool, and 35.7% were from water samples. Salmonella isolates were resistant to antimicrobials with specific resistance rates 58.82% for cefoxitin (95%Rn: 42.28 - 75.37), 41.2% (95%Rn: 24.63 - 57.72) for ampicillin and 35.3% (95%Rn: 19.23 - 51.36) for tetracycline. Low resistance pattern was reported in chloramphenicol 17.65% and nalidixic acid 14.71%.
Conclusions: The study highlights the high prevalence of Antimicrobial-resistant Salmonella, a significant public health concern, emphasizing the need for effective surveillance, control measures, biosecurity, Mandatory abattoir worker training, and Antimicrobial stewardship in livestock.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12345083 | PMC |
http://dx.doi.org/10.1186/s12866-025-04262-3 | DOI Listing |
Mol Biol Rep
September 2025
Department of Medical Lab Technology, College of health and medical technology, Sulaimani Polytechnic University, Sulaimani, 46001, Kurdistan Region, Iraq.
Background: Sinusitis is a common respiratory infection increasingly associated with antibiotic-resistant Staphylococcus aureus, posing significant treatment challenges. The emergence of methicillin-resistant S. aureus (MRSA) in sinus infections necessitates comprehensive profiling of resistance patterns to guide effective therapy.
View Article and Find Full Text PDFMicrobiol Spectr
September 2025
JMI Laboratories/Element Materials Technology, North Liberty, Iowa, USA.
Increasing rates of antimicrobial resistance require additional safe and effective options for managing difficult-to-treat infections. SPR206 is a next-generation polymyxin with improved safety profiles. This study determined the activity of SPR206 against a diverse collection of gram-negative isolates.
View Article and Find Full Text PDFFront Microbiol
August 2025
Department of Clinical Sciences, College of Veterinary Medicine, Kansas State University, Manhattan, KS, Unites States.
Globally, and have been associated with human gastroenteritis. More importantly, there are increasing reports of strains that are resistant to commonly used antimicrobials. In Rwanda, the prevalence and the antimicrobial susceptibility profiles of thermophilic strains remain underexplored.
View Article and Find Full Text PDFCan Vet J
September 2025
Marie-Lou Gauthier, DMV, ACVM is a Veterinary Microbiologist at the Laboratoire de santé animale (Ministère de l'Agriculture, des Pêcheries et de l'Alimentation du Québec) and the Centre de Diagnostic Vétérinaire de l'Université de Montréal (University of Montreal).
Antimicrob Steward Healthc Epidemiol
September 2025
Emergency and Trauma Centre, Royal Brisbane and Women's Hospital, Brisbane, Australia.
Objective: To determine the frequency and outcomes of early follow-up blood cultures (BCs) collected within 48 hours of patients being investigated for bacteremia in the emergency department (ED), as well as the number of new pathogens isolated.
Design: Retrospective observational study of patients who had BCs collected in the ED between October 2019 and July 2020.
Methods: This study was conducted in a large, metropolitan ED with annual census of over 82,000 adult presentations.